Skip to main content
ZNTL logo

Zentalis Pharmaceuticals, Inc.

ZNTLNASDAQHealthcareBiotechnology

$1.98Today:- (-)1Y +46.95%

As of Oct 27, 2026 close

Market cap
$141.23M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.21$6.95
Volume (live)
-
Avg. volume (3M)
1.36M

Zentalis Pharmaceuticals, Inc. (ZNTL) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Zentalis Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
(9 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$7.67
+287.37% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest ZNTL Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Andres Y. Maldonado
HC Wainwright
BuyMaintains
$10.00
Unknown Analyst
Leerink Partners
BuyUpgrades
$4.00 → $8.00
Yanan Zhu
Wells Fargo
HoldMaintains
$5.00
Matt Phipps
William Blair
BuyInitiates
-
Edmund Ingham
Forbes
BuyInitiates Coverage
-
Graig Suvannavejh
Mizuho
BuyReiterates
$8.00
Michael Schmidt
Guggenheim
BuyMaintains
$10.00
Andres Y. Maldonado
HC Wainwright
BuyMaintains
$10.00
Michael Ulz
Morgan Stanley
HoldMaintains
$4.00 → $5.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 23, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for ZNTL?

The analyst consensus rating for ZNTL is Buy, based on the latest ratings from 8 analysts over the last 90 days.

What is the average price target for ZNTL?

The average 12-month price target for ZNTL is $7.67, representing an upside of 287.4% from the Oct 27, 2026 close of $1.98.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.